People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

There may soon be a new medication option for losing weight. Eli Lilly's experimental pill appears to work as well as the ...

as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative for weight loss and diabetes. Get top local stories in Southern California delivered to you every morning.

Eli Lilly shares are now positive for the year, up 10% since the start of January.

Eli Lilly said in February that it will invest at least $27 billion to build four new manufacturing sites in the U.S. as ...

Shares in pharmaceuticals firm Eli Lilly (LLY) ballooned higher today after revealing its new needle-free weight loss drug had performed ...

as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative for weight loss and diabetes. "This could join a growing toolbox of medications for obesity, and it ...